SCLL.OB Insider Trading Activity and SEC Form 4 Filings
SCLL.OB insider trading summary
No open-market insider purchases or sales of Stem Cell Innovations, Inc. (SCLL.OB) have been reported on SEC Form 4 in the past 12 months.
Latest SCLL.OB insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 3, 2008 | James H Kelly | Chief Executive Officer | Sell | $580 (44,633 @ $0.01) |
| Feb 29, 2008 | James H Kelly | Chief Executive Officer | Sell | $90K (8,200,000 @ $0.01) |
| Jan 3, 2008 | James H Kelly | Chief Executive Officer | Sell | $4K (400,000 @ $0.01) |
| Jan 2, 2008 | James H Kelly | Chief Executive Officer | Sell | $5K (541,881 @ $0.01) |
| Dec 26, 2007 | James H Kelly | Chief Executive Officer | Sell | $2K (173,486 @ $0.01) |
| Dec 19, 2007 | James H Kelly | Chief Executive Officer | Sell | $2K (180,000 @ $0.01) |
| Dec 18, 2007 | James H Kelly | Chief Executive Officer | Sell | $3K (250,000 @ $0.01) |
| Dec 17, 2007 | James H Kelly | Chief Executive Officer | Sell | $2K (155,000 @ $0.01) |
| Dec 13, 2007 | James H Kelly | Chief Executive Officer | Sell | $3K (200,000 @ $0.01) |
| Dec 12, 2007 | James H Kelly | Chief Executive Officer | Sell | $1K (115,000 @ $0.01) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.